Share Email Print

Proceedings Paper

OmniGuide photonic bandgap fibers for flexible delivery of CO2 laser energy for laryngeal and airway surgery
Author(s): David Torres; Ori Weisberg; Gil Shapira; Charalambos Anastassiou; Burak Temelkuran; Max Shurgalin; Steven Alan Jacobs; Rokan U. Ahmad; Tairan Wang; Uri Kolodny; Stanley M. Shapshay M.D.; Zimmern Wang M.D.; Anand K. Devaiah; Urmen D. Upadhyay; Jamie A. Koufman M.D.
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The CO2 laser is the most widely used laser in laryngology, offering very precise cutting, predictable depth of penetration, and minimal collateral damage due to the efficient absorption of CO2 laser by water. Surgical applications of CO2 laser in microlaryngoscopy include removal of benign lesions and early-stage laryngeal cancer. A Transoral Laser Microsurgery (TLM) approach is routinely employed for treatment of laryngeal cancer; however, the role of TLM in advanced malignant lesions remains controversial. The main limiting factor of TLM is the restrictive exposure of the endoscopes combined with the limited cutting ability offered by the existing micromanipulator, enabling cutting only along the straight line-of-sight axis. A flexible fiber delivery system offering a very high quality output beam can offer tangential cutting and can therefore significantly enhance the existing surgical capabilities. Moreover, a flexible fiber for CO2 laser delivery can be used for treatment of benign conditions through flexible endoscopy in an office setting using local anesthesia. OmniGuide Communications Inc. (OGCI) has fabricated a photonic bandgap fiber capable of flexibly guiding CO2 laser energy. Results of laryngeal in-vivo and in-vitro animal studies will be presented. We will discuss the system setup, fiber performance and clinical outcomes. In addition we will present the results of the first human treatment and highlight additional otolaryngology conditions, which will likely benefit from the new technology herein presented.

Paper Details

Date Published: 25 April 2005
PDF: 12 pages
Proc. SPIE 5686, Photonic Therapeutics and Diagnostics, (25 April 2005); doi: 10.1117/12.590355
Show Author Affiliations
David Torres, OmniGuide Communications Inc. (United States)
Ori Weisberg, OmniGuide Communications Inc. (United States)
Gil Shapira, OmniGuide Communications Inc. (United States)
Charalambos Anastassiou, OmniGuide Communications Inc. (United States)
Burak Temelkuran, OmniGuide Communications Inc. (United States)
Max Shurgalin, OmniGuide Communications Inc. (United States)
Steven Alan Jacobs, OmniGuide Communications Inc. (United States)
Rokan U. Ahmad, OmniGuide Communications Inc. (United States)
Tairan Wang, OmniGuide Communications Inc. (United States)
Uri Kolodny, OmniGuide Communications Inc. (United States)
Stanley M. Shapshay M.D., Boston Medical Ctr. (United States)
Zimmern Wang M.D., Boston Medical Ctr. (United States)
Anand K. Devaiah, Boston Medical Ctr. (United States)
Urmen D. Upadhyay, Boston Medical Ctr. (United States)
Jamie A. Koufman M.D., Wake Forest Univ. Health Sciences (United States)

Published in SPIE Proceedings Vol. 5686:
Photonic Therapeutics and Diagnostics
Brian Jet-Fei Wong M.D.; Eugene A. Trowers M.D.; Kenton W. Gregory M.D.; Abraham Katzir; Nikiforos Kollias; Reza S. Malek M.D.; Henry Hirschberg M.D.; Kenneth Eugene Bartels D.V.M.; Steen J. Madsen; Lloyd P. Tate V.D.M.; Lawrence S. Bass M.D.; Werner T. W. de Riese; Karen M. McNally-Heintzelman, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?